| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2017.08.008 |
| P698 | PubMed publication ID | 28842296 |
| P50 | author | Jordi Colmenero | Q39185659 |
| Lluís Castells | Q56599864 | ||
| Martin Prieto | Q57217333 | ||
| Xavier Xiol | Q63869666 | ||
| Gloria Sanchez Antolin | Q75407662 | ||
| P2093 | author name string | Sonia Pascual | |
| Xavier Forns | |||
| María-Carlota Londoño | |||
| Esther Molina | |||
| Magdalena Salcedo | |||
| Álvaro Giráldez | |||
| Angel Rubin | |||
| Begoña Santos | |||
| Carmen Vinaixa | |||
| Elena Otón | |||
| Flor Nogueras | |||
| Isidoro Narváez | |||
| José Ignacio Herrero | |||
| José Luis Montero | |||
| Juan Manuel Pascasio | |||
| Luisa González-Diéguez | |||
| María Luisa Manzano | |||
| María Teresa Ferrer | |||
| Milagros Testillano | |||
| Sara Lorente | |||
| P433 | issue | 6 | |
| P304 | page(s) | 1168-1176 | |
| P577 | publication date | 2017-08-22 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation | |
| P478 | volume | 67 |
| Q88288702 | Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate |
| Q89623916 | Controversies in the management of hepatocellular carcinoma |
| Q59349328 | De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era |
| Q89924065 | Eliminating viral hepatitis C in Belgium: the micro-elimination approach |
| Q61813946 | HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation |
| Q90834044 | Hepatitis C |
| Q91344731 | Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma |
| Q56364379 | Novel perspectives in the management of decompensated cirrhosis |
| Q90135434 | PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age |
| Q90079314 | Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study |
| Q90319478 | Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort) |
| Q47546983 | Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates |
Search more.